Is polarity of recurrence related to serum lithium level in patients with bipolar disorder?

European Archives of Psychiatry and Clinical Neuroscience

Volumn 255, Issue 1, 2005, Pages 72-74

  Kleindienst, N ^a   Severus, W E ^a   Moller H J ^a   Greil, W ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b Psychiat Priv Clin Sanat K   (Switzerland)

Author keywords

Bipolar disorder; Drug dose response relationship; Lithium; Review

Indexed keywords

LITHIUM;

ARTICLE; BIPOLAR DISORDER; COMPARATIVE STUDY; DEPRESSION; HUMAN; HYPOMANIA; LITHIUM BLOOD LEVEL; MEDICAL LITERATURE; PRIORITY JOURNAL; PUBLICATION; RECURRENT DISEASE; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW;

BIPOLAR DISORDER; CHI-SQUARE DISTRIBUTION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LITHIUM; RANDOMIZED CONTROLLED TRIALS; RECURRENCE;

EID: 17644404735     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-005-0574-x     Document Type: Article

References (22)

1. Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, Pope HG Jr, Chou JC, Keck PE Jr, Rhodes LJ, Swann AC, Hirschfeld RM, Wozniak PJ (2000) A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 57:481-489
2. Bowden CL, Calabrese JR, Sachs G, Yatham LN, Asghar SA, Hompland M, Montgomery P, Earl N, Smoot TM, DeVeaugh-Geiss J; Lamictal 606 Study Group (2003) A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 60:392-400
3. Calabrese JR, Bowden CL, Sachs G, Yatham LN, Behnke K, Mehtonen OP, Montgomery P, Ascher J, Paska W, Earl N, DeVeaugh-Geiss J; Lamictal 605 Study Group (2003) A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Depressed Patients with Bipolar I Disorder. J Clin Psychiatry 64:1013-1024
4. Coppen A, Montgomery SA, Gupta RK, Bailey JE (1976) A double-blind comparison of lithium carbonate and maprotiline in the prophylaxis of the affective disorders. Br J Psychiatry 128: 479-485
5. Cundall RL, Brooks PW, Murray LG (1972) A controlled evaluation of lithium prophylaxis in affective disorders. Psychol Med 2:308-311
6. Gelenberg AJ, Kane JM, Keller MB, Lavori P, Rosenbaum JF, Cole K, Lavelle J (1989) Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 321:1489-1493
7. Hartong EG, Moleman P, Hoogduin CA, Broekman TG, Nolen WA; LitCar Group (2003) Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients. J Clin Psychiatry 64:144-151
8. Johnston BB, Naylor GJ, Dick EG, Hopwood SE, Dick DA (1980) Prediction of clinical course of bipolar manic depressive illness treated with lithium. Psychol Med 10:329-334
9. Kane JM, Quitkin FM, Rifkin A, Ramos-Lorenzi JR, Nayak DD, Howard A (1982) Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison. Arch Gen Psychiatry 39: 1065-1069
10. Kleindienst N, Severus WE, Greil W (2004) Are low lithium levels needed to prevent bipolar depression and high lithium levels to prevent mania? (submitted)
11. Kocsis JH, Stokes PE (1979) Lithium maintenance: factors affecting outcome Am J Psychiatry 136:563-566
12. Lusznat RM, Murphy DP, Nunn CM (1988) Carbamazepine vs lithium in the treatment and prophylaxis of mania. Br J Psychiatry 153:198-204
13. Mendlewicz J, Fieve RR, Stallone F (1973) Relationship between the effectiveness of lithium therapy and family history. Am J Psychiatry 130:1011-1013
14. Perlis RH, Sachs GS, Lafer B, Otto MW, Faraone SV, Kane JM, Rosenbaum JF (2002) Effect of abrupt change from standard to low serum levels of lithium: a reanalysis of double-blind lithium maintenance data. Am J Psychiatry 159:1155-1159
15. Persson G (1972) Lithium prophylaxis in affective disorders. An open trial with matched controls. Acta Psychiatr Scand 90: 295-297
16. Prien RF, Caffey EM Jr, Klett J (1973) Prophylactic efficacy of lithium carbonate in manic depressive illness. Arch Gen Psychiatry 28:337-341
17. Prien RF, Kupfer DJ, Mansky PA, Small JG, Tuason VB, Voss CB, Johnson WE (1984) Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. Arch Gen Psychiatry 41:1096-1104
18. Quitkin FM, Kane J, Rifkin A, Ramos-Lorenzi JR, Nayak DV (1981) Prophylactic lithium carbonate with and without imipramine for bipolar I patients. A double-blind study. Arch Gen Psychiatry 38:902-907
19. Severus WE, Grunze H, Kleindienst N, Möller HJ (2004) The efficacy of lithium as maintenance treatment in bipolar disorder in the light of new approval studies: lithium level as main focus of efficacy (submitted)
20. Stallone F, Shelley E, Mendlewicz J, Fieve RR (1973) The use of lithium in affective disorders. 3. A double-blind study of prophylaxis in bipolar illness. Am J Psychiatry 130:1006-1010
21. Tohen M, Marneros A, Greil W, Calabrese JR, Sachs GS, Yatham LN, Müller-Oerlinghausen B, Koukopoulos A, Cassano GB, Grunze H, Licht RW, Dell'Osso L, Evans AR, Risser R, Baker RW, Crane H, Dossenbach MR, Bowden CL (2004) Olanzapine versus lithium in relapse/recurrence prevention in bipolar disorder: a randomized double-blind controlled 12-month clinical trial. Am J Psychiatry (in press)
22. Waters B, Lapierre Y, Gagnon A, Cahudhry R, Tremblay A, Sarantidis D, Gray R (1982) Determination of the Optimal Concentration of Lithium for the Prophylaxis of Manic-Depressive Disorder. Biol Psychiatry 17:1323-1329